Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Elevated p53 protein expression; a predictor of relapse in rare chronic myeloid malignancies in children?

Pediatric hematology and oncology - 1 May 2014

Honkaniemi Emma, Mattsson Kristin, Barbany Gisela, Sander Birgitta, Gustafsson Britt

Abstract excerpt

BACKGROUND: Alterations in the tumor suppressor gene TP53 have been associated with poor outcome in adult hematological malignancies. We have earlier reported an increased expression of the TP53 encoded protein p53, in bone marrow samples from pediatric patients with aggressive leukemia. Our aim was now to evaluate p53 protein expression at different time points before and after hematopoietic stem cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Gene Expression Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to Infant

Share to Infant, Newborn

Share to Predictive Value of Tests

Share to Recurrence

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 24761810
DOI: 10.3109/08880018.2014.898723

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Elevated p53 protein expression; a predictor of relapse in rare chronic myeloid malignancies in children?PMID 24761810Read ↗

TP53 isoform dysregulation in pediatric B-ALL: identifying markers of favorable prognosis and relapse-associated dynamic.Semantic proximity Read ↗

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.Semantic proximity Read ↗

Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis.Semantic proximity Read ↗

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.Semantic proximity Read ↗

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis.Semantic proximity Read ↗

Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.Semantic proximity Read ↗

Development of TP53 mutations over the course of therapy for acute myeloid leukemia.Semantic proximity Read ↗

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.Semantic proximity Read ↗

Results of p53 analysis in pediatric malignancies in Poland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.